2005-2009 Life Sciences and Health Care Insights
Welcome to Deloitte Life Sciences & Health Care Insights from 2005-2009. Keep up-to-date with the latest thinking on key industry topics with our catalogue of publications, articles, research studies, industry surveys, discussion papers, podcasts, webcasts, newsletters and features. View related studies and reports on the global Deloitte website.
|Shared services in hospitals: it's your turn
Good use of shared services can greatly assist hospitals navigate economic challenges without compromising patient care quality.
Deloitte perspective, November 2009 | 20 pages
|Health technology assessment: involving consumers
Identifies best practice HTA systems for managing the introduction, use and reimbursement of new technologies, including medicines.
Deloitte Economics study for Eli Lilly, October 2009 | 89 pages
|Towards a national e-health strategy
Adam Powick, Deloitte Consulting partner gives his perspective on the key challenges of the e-Health National Agenda.
Deloitte perspective, July 2009 | 22 pages
|Economic cost of spinal cord & traumatic brain injury
Quantifies the economic impact and burden of disease of SCI/TBI and the cost-effectiveness of a range of interventions.
Access Economics, June 2009 | 116 pages
|Release Management: Effective practices for IT delivery
Includes a case study demonstrating results achieved from implementing effective practices at a large US-based health plan.
Article, 2009 | 8 pages
|Health care consumerism
Examines the changing needs of customers & the opportunities & challenges for health plans.
Survey report, 2009 | 8 pages
|National e-Health Strategy: summary
Framework & plan to guide national co-ordination & collaboration in e-health, incorporating an incremental & staged approach.
Report for Australian Health Ministers' Advisory Council, Dec 2008 | 32 pages
|The future of life sciences industries
Predicts trends in consolidation, diverging pharma and biotech futures, growth in Asian markets and growing difficulty in innovation.
Deloitte / Economist Intelligence Unit white paper, October 2008 | 40 pages
|Improving the use of medicines: pharmacogenomics
Argues the case for PGx in avoiding the trial and error and adverse drug events inherent in current methods of drug prescription.
Study for Australian Centre for Health Research, October 2008 | 92 pages
|Connected care: Technology-enabled health care at home
Explores the use of in-home devices in tandem with care programs for chronic disease self-care & post-acute discharge monitoring.
Deloitte Centre for Health Solutions, September 2008 | 16 pages
|The medical home: A solution?
Explores a long-term strategy for unmanaged chronic health conditions as one starting point for reducing health system expenses.
Deloitte Centre for Health Solutions, September 2008 | 18 pages
|Protecting life sciences innovation in emerging markets
A paper presented at the Healthcare Governors session at the World Economic Forum in DAVOS by Deloitte global head LSHC.
World Forum conference paper, January 2008 | 8 pages
|The economic impact of allergic disease in Australia
Report for the Australasian Society of Clinical Immunology and Allergy covering lost productivity and health care expenditure.
Deloitte Access Economics, November 2007 | 123 pages
|Pandemic flu: preparation, productivity &profitability
A summary of discussion at the roundtable sponsored by the Deloitte Centre for Health Solutions and Akin Gump Strauss Hauer & Feld.
Discussion summary, December 2005 | 6 pages